Cabergoline Side Effects
>>>Help Community - Post Your Cabergoline Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Cabergoline Side Effects
Cabergoline Safety Reports reported to FDA
Total Cabergoline reports: 145.Cabergoline FDA safety alerts: No.
Reported deaths: 10 Reported hospitalizations: 50.
Take Cabergoline Side Effects Survey or Share Your Cabergoline Story.
Reported Cabergoline Side Effects: mitral valve incompetence, cardiac valve disease, aortic valve incompetence, aortic valve sclerosis, oedema peripheral, interstitial lung disease, mitral valve disease, pleural effusion, heart valve insufficiency, pneumonia aspiration, nausea.
Cabergoline Usage.
If you have questions about Cabergoline, you can ask a Health Expert or Ask Patient Community about Cabergoline.
< Previous Showing 101-145 of 145
Cabergoline Side Effects Report #5130021-5Health Professional from UNITED KINGDOM reported CABERGOLINE problem on Oct 02, 2006. Female patient, 35 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: nausea, premature labour, vomiting. CABERGOLINE dosage: 2 MG. During the same period patient was treated with MADOPAR, ORPHENADRINE CITRATE, STALEVO, FOLIC ACID, GAVISCON. Patient recovered.
Cabergoline Side Effects Report #5130024-0
CABERGOLINE problem was reported by a Health Professional from UNITED KINGDOM on Oct 02, 2006. Female patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: premature baby, premature labour. CABERGOLINE dosage: 2 MG. During the same period patient was treated with MADOPAR, ORPHENADRINE CITRATE, STALEVO, FOLIC ACID, GAVISCON. Patient died on 09/16/2006.
Cabergoline Side Effects Report #5131811-5
Health Professional from UNITED KINGDOM reported CABERGOLINE problem on Oct 02, 2006. Female patient, weighting 211.6 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: pathological gambling. CABERGOLINE dosage: 3 MG (1 MG, 3 IN 1 D), ORAL. During the same period patient was treated with BENZHEXOL, BISOPROLOL FUMARATE. Patient recovered.
Cabergoline Side Effects Report #5131828-0
CABERGOLINE problem was reported by a Physician from DENMARK on Oct 02, 2006. Male patient, 72 years of age, weighting 174.2 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, ascites, atrioventricular block third degree, coronary artery disease, coronary artery occlusion, dilatation atrial, ejection fraction decreased, oedema peripheral, pericardial effusion. CABERGOLINE dosage: 4 MG (4 MG, 1 IN 1 D); ORAL. During the same period patient was treated with ASPIRIN, SELEGILINE, IMDUR, FUROSEMIDE, ODRIK, SPIRIX, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5133114-1
Physician from JAPAN reported CABERGOLINE problem on Oct 04, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema. CABERGOLINE dosage: unknown. During the same period patient was treated with PARLODEL. Patient recovered.
Cabergoline Side Effects Report #5133143-8
CABERGOLINE problem was reported by a Health Professional from UNITED KINGDOM on Oct 04, 2006. Female patient, 57 years of age, weighting 176.4 lb, was diagnosed with dementia, cardiac failure and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, atrial fibrillation. CABERGOLINE dosage: 1 MG (1 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BUMETANIDE, RIVASTIGMINE TARTRATE, ZOFRAN. Patient recovered.
Cabergoline Side Effects Report #5133242-0
Physician from GERMANY reported CABERGOLINE problem on Oct 05, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5133765-4
CABERGOLINE problem was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness, fall, fatigue, gait disturbance, illusion. CABERGOLINE dosage: 1.5 MG (1 D), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.
Cabergoline Side Effects Report #5135968-1
Physician from JAPAN reported CABERGOLINE problem on Oct 11, 2006. Female patient, 28 years of age, was diagnosed with hyperprolactinaemia, stomach discomfort and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage subcutaneous, increased tendency to bruise, prothrombin time prolonged. CABERGOLINE dosage: 0.25 MG (0.25 MG, 1 IN 1 WK). During the same period patient was treated with GASMOTIN. Patient recovered.
Cabergoline Side Effects Report #5135969-3
CABERGOLINE problem was reported by a Physician from DENMARK on Oct 10, 2006. Male patient, 72 years of age, weighting 174.2 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, atrioventricular block third degree, coronary artery occlusion, dilatation atrial, electrocardiogram st segment elevation, pericardial effusion, pericardial fibrosis, pericarditis constrictive, right ventricular failure. CABERGOLINE dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, SELEGILINE, IMDUR, FUROSEMIDE, ODRIK, SPIRIX, POTASSIUM CHLORIDE, DIOVAN COMP. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5140671-8
Pharmacist from JAPAN reported CABERGOLINE problem on Oct 12, 2006. Female patient, 65 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: confusional state, delirium. CABERGOLINE dosage: 2 MG (2 MG,1 IN 1 D),ORAL. During the same period patient was treated with LIPITOR, ALPRAZOLAM, HALCION. Patient recovered.
Cabergoline Side Effects Report #5140845-6
CABERGOLINE problem was reported by a Pharmacist from NORWAY on Oct 16, 2006. Male patient, 83 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aggression, libido increased, parkinsonism. CABERGOLINE dosage: unknown. During the same period patient was treated with EXELON. Patient was hospitalized. Patient died.
Cabergoline Side Effects Report #5140999-1
Physician from JAPAN reported CABERGOLINE problem on Oct 13, 2006. Male patient was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: malnutrition, pulmonary oedema. CABERGOLINE dosage: unknown. During the same period patient was treated with PARLODEL. Patient recovered.
Cabergoline Side Effects Report #5141067-5
CABERGOLINE problem was reported by a Physician from GERMANY on Oct 16, 2006. Female patient, 82 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, colitis ischaemic, colitis ulcerative, disease recurrence, dysphagia, gastrointestinal necrosis, pneumonia, shock. CABERGOLINE dosage: 0.5 MG (1 IN 1 D) ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5144554-9
Physician from GERMANY reported CABERGOLINE problem on Oct 18, 2006. Male patient, 45 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence. CABERGOLINE dosage: 6 MG, ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5150280-2
CABERGOLINE problem was reported by a Health Professional from UNITED STATES on Nov 10, 2006. Female patient, child 11 years of age, weighting 194.0 lb, was diagnosed with hypopituitarism, pituitary tumour benign and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: flushing, hot flush, insomnia, mood altered, staring. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5150532-6
Physician from SPAIN reported CABERGOLINE problem on Oct 26, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: atrial hypertrophy, electrocardiogram st segment depression, mitral valve incompetence, tricuspid valve incompetence. CABERGOLINE dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.
Cabergoline Side Effects Report #5150533-8
CABERGOLINE problem was reported by a Consumer or non-health professional from SWEDEN on Oct 26, 2006. Female patient, 35 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, pleural fibrosis. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5150896-3
Physician from JAPAN reported CABERGOLINE problem on Oct 26, 2006. Female patient, 63 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve calcification, aortic valve incompetence, blood pressure increased, cardiac murmur, cardiac valve disease, electrocardiogram st segment abnormal, mitral valve disease, tricuspid valve disease. CABERGOLINE dosage: 4 MG (1 D),ORAL. Patient recovered.
Cabergoline Side Effects Report #5151974-5
CABERGOLINE problem was reported by a Physician from UNITED KINGDOM on Oct 27, 2006. Male patient, weighting 7.10 lb, was diagnosed with hyperprolactinaemia and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: foetal heart rate decreased, induced labour, neonatal disorder, pneumonitis. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5154439-X
Physician from GERMANY reported CABERGOLINE problem on Nov 02, 2006. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, dyspnoea exertional, mitral valve incompetence. CABERGOLINE dosage: 12 MG, ORAL. During the same period patient was treated with COMTESS, SINEMET. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5156861-4
CABERGOLINE problem was reported by a Physician from JAPAN on Oct 02, 2006. Male patient, 84 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. CABERGOLINE dosage: 0.75 MG (1 D), ORAL. During the same period patient was treated with MADOPAR, ARICEPT. Patient recovered.
Cabergoline Side Effects Report #5161996-6
Physician from SPAIN reported CABERGOLINE problem on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. CABERGOLINE dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.
Cabergoline Side Effects Report #5164972-2
CABERGOLINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Male patient, 40 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: pathological gambling. CABERGOLINE dosage: 6 MG (6 MG, 1 IN 1 D), ORAL. Patient recovered.
Cabergoline Side Effects Report #5165034-0
Physician from GERMANY reported CABERGOLINE problem on Nov 14, 2006. Male patient, 45 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, aortic valve sclerosis, pulmonary hypertension, tricuspid valve incompetence, ventricular hypertrophy. CABERGOLINE dosage: 6 MG (1 D); ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, AMANTADINE, SELEGILINE, MADOPAR. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5167219-6
CABERGOLINE problem was reported by a Physician from JAPAN on Nov 17, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pleural effusion, vomiting. CABERGOLINE dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5176562-6
Physician from JAPAN reported CABERGOLINE problem on Nov 24, 2006. Female patient, 67 years of age, weighting 84.66 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aortic valve incompetence, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chest discomfort, leukaemia, malaise, mitral valve incompetence, oedema peripheral. CABERGOLINE dosage: 4 MG (1 D), ORAL. During the same period patient was treated with LUVOX, JUVELA NICOTINATE, CEROCRAL, RIZE, KOLANTYL, ULCERMIN, GRAMALIL, HYDREA. Patient was hospitalized. Patient died on 10/22/2006.
Cabergoline Side Effects Report #5179730-2
CABERGOLINE problem was reported by a Health Professional from GERMANY on Nov 29, 2006. Female patient, 82 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, anaemia postoperative, colitis ischaemic, colitis ulcerative, dysphagia, gastrointestinal necrosis, haematemesis, intestinal infarction. CABERGOLINE dosage: 0.5 MG (1 IN 1 D), ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, CIPROFLOXACIN. Patient was hospitalized. Patient died on 08/18/2006.
Cabergoline Side Effects Report #5179879-4
Physician from JAPAN reported CABERGOLINE problem on Nov 28, 2006. Female patient, 65 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: gait disturbance, hallucination, tremor. CABERGOLINE dosage: 2 MG (2 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LIPITOR, ALPRAZOLAM, HALCION. Patient recovered.
Cabergoline Side Effects Report #5179920-9
CABERGOLINE problem was reported by a Physician from JAPAN on Nov 29, 2006. Male patient, 58 years of age, weighting 180.8 lb, was diagnosed with pituitary tumour benign and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: meningitis. CABERGOLINE dosage: (0.5 MG, 2 IN 1 WK); ORAL. During the same period patient was treated with CORTRIL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5191642-7
Physician from JAPAN reported CABERGOLINE problem on Dec 06, 2006. Male patient, 81 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: affect lability, agitation, anxiety, cardiovascular disorder, cerebral atrophy, cognitive disorder, delirium, dementia, disorientation. CABERGOLINE dosage: 50 MG, ORAL. During the same period patient was treated with TANDOSPIRONE CITRATE, DONEPEZIL, LEVODOPA, QUETIAPINE FUMARATE, TIAPRIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5192002-5
CABERGOLINE problem was reported by a Physician from JAPAN on Dec 11, 2006. Male patient, 84 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pleural effusion. CABERGOLINE dosage: 0.75 MG (3 IN 1 D), ORAL. During the same period patient was treated with ASPIRIN, NEUQUINON, BIOFERMIN R, GASMOTIN, FERROMIA, MADOPAR, ARICEPT. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5377749-X
Health Professional from GERMANY reported CABERGOLINE problem on June 21, 2007. Male patient, weighting 176.4 lb, was diagnosed with parkinsonism and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: skin necrosis. CABERGOLINE dosage: DAILY DOSE:4MG. Patient recovered.
Cabergoline Side Effects Report #5385694-9
CABERGOLINE problem was reported by a Physician from GERMANY on July 02, 2007. Female patient, weighting 174.2 lb, was diagnosed with restless legs syndrome and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, aortic valve sclerosis. CABERGOLINE dosage: DAILY DOSE:1MG. Patient recovered.
Cabergoline Side Effects Report #5401755-X
Physician from JAPAN reported CABERGOLINE problem on July 19, 2007. Female patient, 71 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: mitral valve incompetence. CABERGOLINE dosage: DAILY DOSE:1MG. Patient recovered.
Cabergoline Side Effects Report #5409998-6
CABERGOLINE problem was reported by a Pharmacist from JAPAN on July 31, 2007. Male patient, 78 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: heart valve calcification, sputum retention. CABERGOLINE dosage: DAILY DOSE:2MG. During the same period patient was treated with MENESIT, EPADEL, NAUZELIN. Patient recovered.
Cabergoline Side Effects Report #5414055-9
Physician from JAPAN reported CABERGOLINE problem on Aug 02, 2007. Female patient, 81 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: mitral valve incompetence. CABERGOLINE dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5414313-8
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 72 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence, dyspnoea, oedema peripheral, palpitations. CABERGOLINE dosage: unknown. During the same period patient was treated with DOPASTON, TOLEDOMIN, THYRADIN S. Patient recovered.
Cabergoline Side Effects Report #5425373-2
Physician from JAPAN reported CABERGOLINE problem on Aug 13, 2007. Male patient, 78 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: heart valve calcification, sputum retention. CABERGOLINE dosage: unknown. During the same period patient was treated with MENESIT, EPADEL, NAUZELIN. Patient recovered.
Cabergoline Side Effects Report #5446575-5
CABERGOLINE problem was reported by a Physician from JAPAN on Aug 28, 2007. Male patient, weighting 149.9 lb, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: aortic valve incompetence. CABERGOLINE dosage: DAILY DOSE:2MG. During the same period patient was treated with PERMAX, AKINETON, ZANTAC, EC DOPARL, SYMMETREL. Patient recovered.
Cabergoline Side Effects Report #5453124-4
Consumer or non-health professional from reported CABERGOLINE problem on Sept 04, 2007. Female patient, 32 years of age, was diagnosed with hyperprolactinaemia and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood prolactin increased, depression, gastritis, hepatic function abnormal, pancreatic disorder. CABERGOLINE dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5453125-6
CABERGOLINE problem was reported by a Health Professional from UNITED KINGDOM on Sept 03, 2007. Male patient, 54 years of age, was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: pathological gambling. CABERGOLINE dosage: unknown. During the same period patient was treated with ENTACAPONE, TADALAFIL. Patient recovered.
Cabergoline Side Effects Report #5472014-4
Health Professional from UNITED KINGDOM reported CABERGOLINE problem on Sept 17, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease, blood cholesterol increased, dyspnoea, gastrointestinal disorder and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: mitral valve disease, pulmonary fibrosis, pulmonary hypertension. CABERGOLINE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BUMETANIDE, OMEPRAZOLE, TRIHEXYPHENIDYL. Patient recovered.
Cabergoline Side Effects Report #5472052-1
CABERGOLINE problem was reported by a Physician from JAPAN on Sept 19, 2007. Male patient, 60 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: heart valve incompetence. CABERGOLINE dosage: DAILY DOSE:3MG. During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE. Patient recovered.
Cabergoline Side Effects Report #5474726-5
Consumer or non-health professional from UNITED KINGDOM reported CABERGOLINE problem on Sept 14, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: mitral valve disease, pulmonary fibrosis, pulmonary hypertension. CABERGOLINE dosage: 4 MG (4 MG, 1 IN 1 D) ORAL. Patient recovered.
< Previous Showing 101-145 of 145